AI assistant
Cigna Group — Director's Dealing 2024
Jul 11, 2024
29918_dirs_2024-07-10_4da2a4da-748c-4640-bc3e-3c55fcefcd78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-07-01
Reporting Person: Kates Jamie G (Chief Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 1216.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $152.8947 | 2028-03-07 | Common Stock, $.01 Par Value (899.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $183.4405 | 2029-02-27 | Common Stock, $.01 Par Value (471.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $192.0200 | 2030-02-26 | Common Stock, $.01 Par Value (644.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $213.8000 | 2031-02-24 | Common Stock, $.01 Par Value (614.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $227.0200 | 2032-02-23 | Common Stock, $.01 Par Value (704.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $294.6100 | 2033-02-22 | Common Stock, $.01 Par Value (518.0000) | Direct | |
| Employee Stock Option (Right to Buy) | $336.4750 | 2034-02-28 | Common Stock, $.01 Par Value (447.0000) | Direct |
Footnotes
F1: This option is fully vested.
F2: This option was granted on February 23, 2022 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2023 and March 1, 2024, and the last installment becomes exercisable on March 1, 2025.
F3: This option was granted on February 22, 2023, and vests in three equal annual installments. The first installment became exercisable on March 1, 2024, and the next two installments become exercisable on March 1, 2025 and March 1, 2026.
F4: This option vests in three equal annual installments beginning March 1, 2025.